Delivery Order SPE2DR25D2206-SPE2DR26F9AR3
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $5,010.48 firm fixed price delivery order for 100 mg vials of Veklury (remdesivir), a broad-spectrum antiviral medication, with a completion date of December 8, 2025. This competitively awarded, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $3,962.20 to AmerisourceBergen Drug Corp for 100 mg vials of Veklury (remdesivir), a broad-spectrum antiviral medication. This firm fixed-price delivery order, issued on June 3, 2025, with an ultimate completion date of June 25, 2025, represents a non-competitive award under AmerisourceBergen's existing contract vehicle. The pharmaceutical product will be delivered to the company's facility in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a $2,377.32 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 100 mg vials of Veklury (remdesivir), an antiviral medication used in medical treatment protocols. The contract, which is a child award under a larger indefinite delivery vehicle, was competitively awarded without set-aside designation and is scheduled for completion by May 12, 2025. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $5,943.30 to AmerisourceBergen Drug Corp for 100 mg vials of Veklury (remdesivir), an antiviral medication used in treating severe COVID-19 infections. This firm fixed-price delivery order, awarded on August 26, 2025, represents a non-competitive child award under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which carries a ceiling value of $999,999,999.00 through December 2026....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Veklury (remdesivir) 100 mg vials valued at $15,848.80 under a firm fixed-price contract. The award was issued on August 28, 2025, with an ultimate completion date of September 19, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical supply...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,962.20 for 100 mg vials of Veklury (remdesivir), an antiviral medication used in treating certain viral infections. This is a firm fixed price, non-set-aside competitive award with an ultimate completion date of October 2, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 100 mg vials of Veklury (remdesivir) with a potential value of $6,809.20. The award has a completion date of February 28, 2024. Amerisourcebergen Drug Corp, based in Conshohocken, Pennsylvania, is a for-profit prime contractor that provides a wide range of pharmaceutical products and medical supplies to government...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Veklury (Remdesivir) 100 mg vials. The contract is valued at $17,023.00 and has a completion date of August 16, 2024. It is a firm fixed-price contract with no set-aside designation. Amerisourcebergen, through its extensive supply chain and distribution capabilities, will provide this critical antiviral medication to support various...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $4,754.64 for 100 mg vials of Veklury on September 12, 2025, with an ultimate completion date of October 3, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania facility. Veklury (remdesivir) is an antiviral medication used in the treatment of certain serious viral infections and represents part of...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Veklury (Remdesivir) 100 mg vials. The $20,427.60 firm fixed price contract has an ultimate completion date of October 29, 2024. This award is a task order under AmerisourceBergen's Indefinite Delivery Contract valued up to $999,999,999 with DLA Troop Support Medical for a wide range of pharmaceutical and medical...
- SPE2DR25D2206Indefinite Delivery Contract
- SPE2DR25D2206-SPE2DR26F9AR3Delivery Order
The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Veklury (remdesivir) 100 mg vials, with a ceiling value of $5,010.48 and an ultimate completion date of December 1, 2025. This is a firm fixed-price delivery order awarded without set-aside designation, indicating competitive award based on the vendor's demonstrated capability to fulfill federal pharmaceutical procurement requirements. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen has an extensive portfolio of federal contract awards with DLA covering specialty medications, brand-name and generic drugs, vaccines, and specialized medical supplies across multiple therapeutic domains, serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.0k | 11/6/25 |